Lataa...
Effects of GLP-1 and Incretin-Based Therapies on Gastrointestinal Motor Function
Glucagon-like peptide 1 (GLP-1) is a hormone secreted predominantly by the distal small intestine and colon and released in response to enteral nutrient exposure. GLP-1-based therapies are now used widely in the management of type 2 diabetes and have the potential to be effective antiobesity agents....
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Hindawi Publishing Corporation
2011
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3124003/ https://ncbi.nlm.nih.gov/pubmed/21747825 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2011/279530 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|